Jump to content

3-Methoxy-4-ethoxyphenethylamine

From Wikipedia, the free encyclopedia
(Redirected from MEPEA)
3-Methoxy-4-ethoxyphenethylamine
Names
Preferred IUPAC name
2-(4-Ethoxy-3-methoxyphenyl)ethan-1-amine
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.199.597 Edit this at Wikidata
EC Number
  • 674-198-8
UNII
  • InChI=1S/C11H17NO2/c1-3-14-10-5-4-9(6-7-12)8-11(10)13-2/h4-5,8H,3,6-7,12H2,1-2H3 checkY
    Key: AFMUTJRFLRYILG-UHFFFAOYSA-N checkY
  • InChI=1/C11H17NO2/c1-3-14-10-5-4-9(6-7-12)8-11(10)13-2/h4-5,8H,3,6-7,12H2,1-2H3
    Key: AFMUTJRFLRYILG-UHFFFAOYAD
  • COc1cc(ccc1OCC)CCN
  • O(c1ccc(cc1OC)CCN)CC
Properties
C11H17NO2
Molar mass 195.262 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

MEPEA, or 3-methoxy-4-ethoxyphenethylamine, is a lesser-known psychedelic drug. MEPEA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 300 mg, and the duration unknown.[1] MEPEA produces a light lifting feeling and a +1 on the Shulgin Rating Scale. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEPEA.

See also

[edit]

References

[edit]